Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › DE › Newark › NPI 1639113285
Residential

Khan, Mohammad

Khan, Mohammad was paid $669K by Medicaid between Jan 2018 and Nov 2024, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.

33Billing provider infoKHAN, MOHAMMAD
NEWARK, DE 19702
33aNPI1639113285assigned 06/15/2006
28Total paid$669K
24GClaims29,692
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018877$1K
20191,008$4K
20202,773$48K
20215,932$130K
20226,499$209K
20238,577$186K
2024incomplete4,026$91K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 45% 4,583 3,509 $301K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 12% 1,001 769 $79K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 11% 867 721 $74K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.8% 532 451 $46K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.7% 363 314 $31K
96110 Developmental screening, with scoring and documentation, per standardized instrument 3.2% 2,596 2,146 $21K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 3.0% 1,274 850 $20K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 2.4% 481 396 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.2% 2,062 1,652 $15K
90670 1.4% 536 435 $10K
94760 1.2% 7,218 5,513 $8K
90686 1.0% 442 358 $7K
22 more codes
90697 <1% 236 $6K
92551 <1% 725 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 604 $5K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 70 $5K
90680 <1% 244 $4K
86580 <1% 685 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 136 $2K
90633 <1% 168 $2K
99173 <1% 882 $2K
90685 <1% 94 $2K
90710 <1% 78 $1K
90651 <1% 87 $1K
90656 <1% 32 $704.74
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 67 $677.88
90696 <1% 37 $526.97
0071A <1% 19 $520.00
87807 <1% 48 $494.15
90698 <1% 12 $254.87
90480 <1% 20 $244.00
90460 Immunization administration through 18 years of age via any route, first or only component <1% 3,417 $60.00
91307 <1% 24 $0.02
D1206 Topical application of fluoride varnish 0% 52 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.